|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 45/00 | (2006.01) |
| (11) | Number of the document | 3849614 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19780048.5 |
| Date of filing the European patent application | 2019-09-11 | |
| (97) | Date of publication of the European application | 2021-07-21 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-20 |
| (46) | Date of publication of the claims translation | 2024-03-25 |
| (86) | Number | PCT/US2019/050709 |
| Date | 2019-09-11 |
| (87) | Number | WO 2020/056066 |
| Date | 2020-03-19 |
| (30) | Number | Date | Country code |
| 201862729925 P | 2018-09-11 | US | |
| 201962815964 P | 2019-03-08 | US |
| (72) |
CHEN, Sigeng , US
LU, Yingchun , US
RASHID, Md, Harunur , US
KNUDSEN, Nickolas , US
TIAN, Feng , US
|
| (73) |
Ambrx, Inc. ,
10975 North Torrey Pines Road, La Jolla, CA 92037,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Interleukino-2 polipeptido konjugatai ir jų panaudojimas |
| INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND THEIR USES |
| Payment date | Validity (years) | Amount | |
| 2025-08-04 | 7 | 162.00 EUR |
| 2026-09-11 |